EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. A more recent version of this publication is now available: EU Drug Markets: In-depth analysis The analysis presented in this report spans numerous topics...
Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System
In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early warning and risk-assessment activities. This report covers the period from January 2016 until December 2017.
Drugs and the darknet: perspectives for enforcement, research and policy
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they relate to criminal behaviour. The publication adopts an...
EU drug markets report: a strategic analysis
The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the markets for heroin, cocaine, cannabis, amphetamine,...